share_log

Piper Sandler Maintains Overweight on Inspire Medical Systems, Raises Price Target to $255

Piper Sandler Maintains Overweight on Inspire Medical Systems, Raises Price Target to $255

派珀·桑德勒继续增持Inspire Medical Systems,将目标股价上调至255美元
Benzinga ·  05/08 08:12

Piper Sandler analyst Adam Maeder maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and raises the price target from $250 to $255.

派珀·桑德勒分析师亚当·梅德维持增持Inspire Medical Systems(纽约证券交易所代码:INSP),并将目标股价从250美元上调至255美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发